Wolverine Trading’s Transmedics TMDX Stock Holding History

Wolverine Trading’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$7.39M	Buy	65,578 +21,985	+50%	+$2.57M	0.01%	1125
2025 Q2	$5.73M	Buy	43,593 +22,052	+102%	+$2.42M	0.01%	985
2025 Q1	$1.48M	Sell	21,541 -15,578	-42%	-$1.07M	﹤0.01%	1885
2024 Q4	$2.2M	Buy	37,119 +29,099	+363%	+$2.71M	﹤0.01%	1876
2024 Q3	$1.28M	Buy	8,020 +6,457	+413%	+$995K	﹤0.01%	2118
2024 Q2	$235K	Sell	1,563 -4,501	-74%	-$540K	﹤0.01%	3671
2024 Q1	$448K	Buy	6,064 +2,390	+65%	+$197K	﹤0.01%	2943
2023 Q4	$290K	Buy	+3,674	New	+$222K	﹤0.01%	3504
2022 Q1	–	Sell	-12,914	Closed	-$251K	–	6429
2021 Q4	$251K	Buy	+12,914	New	+$324K	﹤0.01%	4387

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wolverine Trading's TMDX Position: Q3 2025 in Review

Wolverine Trading increased its Transmedics (TMDX) stake by 50% in Q3 2025, buying an estimated $2.57M and bringing the position to 65,578 shares worth $7.39M. The position accounts for 0.01% of the portfolio, ranked #1125.

Wolverine Trading first reported a position in TMDX in Q4 2021 and has held it in 9 quarters since. 388 funds tracked by Wall St. Rank hold TMDX as of Q3 2025.

Wolverine Trading held 65,578 shares of Transmedics worth $7.39M as of Q3 2025.
Wolverine Trading bought 21,985 Transmedics shares in Q3 2025, an estimated $2.57M.
Transmedics made up 0.01% of Wolverine Trading's portfolio in Q3 2025, its #1125 holding.
Wolverine Trading first reported a position in Transmedics in Q4 2021 and has held it in 9 quarters since.
388 funds tracked by Wall St. Rank held Transmedics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.